Genotyping may help predict SSRI efficacy

GENOTYPING patients to predict antidepressant effectiveness may be useful in some people, according to new Australian guidelines.

The advice, from a consensus statement for the safety monitoring guidelines of treatments for major depressive disorders, was developed by Australian experts and published last week.